Delivery Order SPE2DR25D2009-SPE2DR26FJ3V7
- Not listed
- The Defense Logistics Agency awarded a $7,863.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors (2 ml vials). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by December 2, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,741.60 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on December 2, 2025, with a completion date of December 3, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $7,697.29 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors (2 ml units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 11, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $105,802.94 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This non-set-aside, firm fixed-price contract is expected to be completed by November 10, 2025, with performance centered at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a $6,356.88 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Dupixent 200 mg/1.14 ml pen injectors. This firm fixed-price delivery order, which is expected to be completed by July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $11,468.93 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors, with a completion date of August 12, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The vendor will perform this work from its corporate office in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $4,602.67 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation and specifies October 28, 2025,...
- The Defense Logistics Agency awarded a $14,957.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors (2 ml units). This non-competitive delivery order represents a continuation of AmerisourceBergen's extensive role as a pharmaceutical supplier to the federal government. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The...
- The Defense Logistics Agency awarded a delivery order valued at $3,603.02 to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dupixent 300 mg/2 ml pen injections (2 ml units). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of December 11, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $129,226.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on December 9, 2025, with completion targeted for December 10, 2025. This non-competitive delivery order is performed from the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ3V7Delivery Order
The Defense Logistics Agency awarded a $7,137.00 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. The contract is scheduled for ultimate completion on December 8, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its comprehensive $999,999,999.00 IDC (SPE2DX) with the DLA, which runs through December 2026. This prime contract vehicle enables the company to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. The current delivery order for Dupixent—a biologic treatment for eczema and other inflammatory conditions—exemplifies the company's role in fulfilling specialized pharmaceutical requirements across the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 12/4/25 |